Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Generic Colchicine Tablets Now FDA-Approved for Familial Mediterranean Fever
    source: pixabay.com

    Generic Colchicine Tablets Now FDA-Approved for Familial Mediterranean Fever

      Recently, Chain Drug Review reported that the FDA had approved a generic form of colchicine pills (normally prescribed as Mitigare, Colcrys, or Gloperba) for the treatment of familial Mediterranean fever (FMF).…

    Continue Reading Generic Colchicine Tablets Now FDA-Approved for Familial Mediterranean Fever
    It’s National Glaucoma Awareness Month!
    source: pixabay.com

    It’s National Glaucoma Awareness Month!

    It's January -- do you know what that means? That's right - it's National Glaucoma Awareness Month! According to the Richmond Register, glaucoma diagnoses are rising on a national level.…

    Continue Reading It’s National Glaucoma Awareness Month!
    Social Media Star Adalia Rose Williams, Who Had Progeria, Has Passed Away
    Screenshot/Instagram: https://www.instagram.com/p/CYqNhVVsGpL/

    Social Media Star Adalia Rose Williams, Who Had Progeria, Has Passed Away

    On January 12, 2022, posts shared on Facebook and Instagram announced the passing of 15-year-old Adalia Rose Williams. A Youtube and Facebook star, Adalia had over 16 million followers collectively.…

    Continue Reading Social Media Star Adalia Rose Williams, Who Had Progeria, Has Passed Away
    Graduate Raises Hypophosphatasia Awareness
    https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/

    Graduate Raises Hypophosphatasia Awareness

    When she was born, Savannha Aretino was diagnosed with hypophosphatasia, a rare genetic disorder characterized by bone and teeth development abnormalities. Now, twenty-three years later, Savannha is working to not…

    Continue Reading Graduate Raises Hypophosphatasia Awareness
    LioCyx-M004 for HBV-Related Hepatocellular Carcinoma Earns Fast Track Designation
    source: pixabay.com

    LioCyx-M004 for HBV-Related Hepatocellular Carcinoma Earns Fast Track Designation

      According to Healio, the U.S. Food and Drug Administration (FDA) recently granted Fast Track designation to LioCyx-M004. This therapy, developed by T-cell immunotherapy company Lion TCR, is designed to…

    Continue Reading LioCyx-M004 for HBV-Related Hepatocellular Carcinoma Earns Fast Track Designation
    INFILTR8: A New and Rare Genetic Disease
    source: pixabay.com

    INFILTR8: A New and Rare Genetic Disease

      Pursuing an education can be difficult enough without any other extraneous factors. But what if you were also battling frequent infections, gastrointestinal problems, and recurrent hospitalizations? For Evan Brandon,…

    Continue Reading INFILTR8: A New and Rare Genetic Disease
    Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity
    https://pixabay.com/en/baby-girl-sleep-child-toddler-1151351/

    Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity

    Orphan Drug designation is typically granted to drugs or biologics intended to treat, prevent, or diagnose rare diseases; in the United States, these are conditions affecting under 200,000 Americans. Drug…

    Continue Reading Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity